Lynparza approved in China as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer Read more
Ultomiris approved in Europe for the treatment of adults with generalised myasthenia gravis Read more
Pfizer to Supply Global Fund Up to 6 Million PAXLOVID Treatment Courses for Low-and-Middle-Income Countries Read more
Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma and Fluidda Read more
Coeptis Therapeutics Enters Exclusive License Agreement with University of Pittsburgh for Rights to SNAP-CAR, a “Multi-Antigen” CAR T Technology Read more
In 4 weeks meet Pfizer, AstraZeneca, DiME & many more at the Biosensors for Medical Wearables Conference Read more